BioTech IP Review

Compositions and Methods for Controlling Cellular Identity

WO2021202564A1

  • Publication: WO2021202564A1 (filed March 30, 2021)
  • Assignee: Altos Labs, Inc.
  • Title: Compositions and Methods for Controlling Cellular Identity
  • Focus: Methods and compositions for controlling what type of cell a cell is — a foundational aspect of cellular reprogramming and rejuvenation technology.

What This Patent Covers

This patent application claims intellectual property around technologies that can influence and control a cell’s identity — meaning how a cell maintains its specialized function or state (for example, a skin cell versus a liver cell):

  • Compositions: It describes chemical, genetic, or biological compositions that can be used to shift a cell from one identity to another, or to stabilize a desired identity.
  • Methods for Control: It includes methods of applying these compositions to cells to provoke changes in gene expression patterns associated with identity — such as resetting epigenetic marks that keep a cell in an aged or differentiated state.
  • Applications: Such methods are foundational to cellular reprogramming, regeneration, and potential reversal of aging‑associated changes in tissues.

In more technical terms, controlling cellular identity involves adjusting the program of gene expression that maintains a cell’s differentiated function, with the goal of reverting it to a more youthful or flexible state without fully dedifferentiating it.

Why This Patent Is Important

1. Core to Altos Labs’ Mission

Altos Labs was founded with the explicit goal of applying partial cellular reprogramming and rejuvenation programming to reverse age‑related decline. Controlling cellular identity is a central scientific mechanism for restoring youthful function while preventing loss of cell fate — a key insight of the company’s strategy.

2. Foundational to Rejuvenation Technology

If cells can be driven away from an aged, dysfunctional state and towards a more resilient, youthful identity without causing dedifferentiation (which risks tumor formation), such technology could underlie therapies for age‑related diseases, tissue degeneration, and regenerative medicine — areas with enormous potential clinical and economic impact.

3. Strategic Intellectual Property Positioning

Even as an application rather than an issued patent, WO2021202564A1 establishes priority around core reprogramming concepts — which could be valuable for licensing, partnerships, and defending future therapies that emerge from Altos’ research pipeline.

4. Enables Broad Platform Development

Controlling cell identity isn’t limited to one tissue type or disease; it has implications for multiple organ systems, regenerative contexts, and aging phenotypes — making it a flexible and potentially lucrative area of IP for long‑term biotech value.

Summary

  • Patent/Application: WO2021202564A1 – Compositions and Methods for Controlling Cellular Identity
  • Filed: March 30, 2021
  • Assignee: Altos Labs, Inc.
  • Focus: Technology for directing and maintaining specific cellular identities — a scientific foundation for cell rejuvenation and reprogramming approaches.
  • Importance: This application protects foundational IP around Altos Labs’ core mission of reversing aging and restoring tissue function, positioning the company strategically in regenerative and rejuvenation biotechnology.

Leave a comment